A complex of Wiskott-Aldrich syndrome protein with mammalian verprolins plays an important role in monocyte chemotaxis

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6576-6585

  Tsuboi, Shigeru ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BETA ACTIN; CYTOSKELETON PROTEIN; GENE PRODUCT; PROTEIN CR16; PROTEIN WICH; UNCLASSIFIED DRUG; VERPROLIN; WISKOTT ALDRICH SYNDROME PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN INTERACTING PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN RELATED PROTEIN;

ACTIN POLYMERIZATION; AMINO TERMINAL SEQUENCE; ARTICLE; CELL MIGRATION; CELL POLARITY; CHEMOTAXIS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECURRENT INFECTION; REGULATORY MECHANISM; WISKOTT ALDRICH SYNDROME; YEAST;

EID: 33646863080     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6576     Document Type: Article

References (63)

1. Wiskott, A. 1937. Familiarer, angeborener Morbus Welhofii? Monatsschr. Kinderheilkd. 68: 212-216.
2. Aldrich, R. A., A. G. Steinberg, and D. C. Campbell. 1954. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13: 133-139.
3. Nonoyama, S., and H. D. Ochs. 1998. Characterization of the Wiskott-Aldrich syndrome protein and its role in the disease. Curr. Opin. Immunol. 10: 407-412.
4. Thrasher, A. J. 2002. WASp in immune-system organization and function. Nat. Rev. Immunol. 2: 635-646.
5. Derry, J. M., H. D. Ochs, and U. Francke. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. [Published erratum appears in 1994 Cell 79: following 922.] Cell 78: 635-644.
6. Higgs, H. N., and T. D. Pollard. 2000. Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J. Cell Biol. 150: 1311-1320.
7. Miki, H., T. Sasaki, Y. Takai, and T. Takenawa. 1998. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP. Nature 391: 93-96.
8. Zeng, R., J. L. Cannon, R. T. Abraham, M. Way, D. D. Billadeau, J. Bubeck-Wardenberg, and J. K. Burkhardt. 2003. SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site. J. Immunol. 171: 1360-1368.
9. Zhang, J., A. Shehabeldin, L. A. da Cruz, J. Butler, A. K. Somani, M. McGavin, I. Kozieradzki, A. O. dos Santos, A. Nagy, S. Grinstein, et al. 1999. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190: 1329-1342.
10. Rengan, R., H. D. Ochs, L. I. Sweet, M. L. Keil, W. T. Gunning, N. A. Lachant, L. A. Boxer, and G. M. Omann. 2000. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood 95: 1283.
11. Rawlings, S. L., G. M. Crooks, D. Bockstoce, L. W. Barsky, R. Parkman, and K. I. Weinberg. 1999. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression. Blood 94: 3872-3882.
12. Prehoda, K. E., J. A. Scott, R. D. Mullins, and W. A. Lim. 2000. Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. Science 290: 801-806.
13. Kim, A. S., L. T. Kakalis, N. Abdul-Manan, G. A. Liu, and M. K. Rosen. 2000. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404: 151-158.
14. Castellano, F., C. Le Clainche, D. Patin, M. F. Carlier, and P. Chavrier. 2001. A WASp-VASP complex regulates actin polymerization at the plasma membrane. EMBO J. 20: 5603-5614.
15. Rohatgi, R., P. Nollau, H. Y. Ho, M. W. Kirschner, and B. J. Mayer. 2001. Nck and phosphatidylinositol 4,5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J. Biol. Chem. 276: 26448-26452.
16. Badour, K., J. Zhang, F. Shi, Y. Leng, M. Collins, and K. A. Siminovitch. 2004. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J. Exp. Med. 199: 99-112.
17. Baba, Y., S. Nonoyama, M. Matsushita, T. Yamadori, S. Hashimoto, K. Imai, S. Arai, T. Kunikata, M. Kurimoto, T. Kurosaki, et al. 1999. Involvement of Wiskott-Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood 93: 2003-2012.
18. Cory, G. O., R. Garg, R. Cramer, and A. J. Ridley. 2002. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation: Wiskott-Aldrich Syndrome protein. J. Biol. Chem. 277: 45115-45121.
19. Torres, E., and M. K. Rosen. 2003. Contingent phosphorylation/ dephosphorylation provides a mechanism of molecular memory in WASP. Mol. Cell 11: 1215-1227.
20. Ho, H. Y., R. Rohatgi, A. M. Lebensohn, M. Le, J. Li, S. P. Gygi, and M. W. Kirschner. 2004. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 118: 203-216.
21. Miki, H., K. Miura, and T. Takenawa. 1996. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15: 5326-5335.
22. Vaduva, G., N. C. Martin, and A. K. Hopper. 1997. Actin-binding verprolin is a polarity development protein required for the morphogenesis and function of the yeast actin cytoskeleton. J. Cell Biol. 139: 1821-1833.
23. Ramesh, N., I. M. Anton, J. H. Hartwig, and R. S. Geha. 1997. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl. Acad. Sci. USA 94: 14671-14676.
24. Kato, M., H. Miki, S. Kurita, T. Endo, H. Nakagawa, S. Miyamoto, and T. Takenawa. 2002. WICH, a novel verprolin homology domain-containing protein that functions cooperatively with N-WASP in actin-microspike formation. Biochem. Biophys. Res. Commun. 291: 41-47.
25. Aspenstrom, P. 2002. The WASP-binding protein WIRE has a role in the regulation of the actin filament system downstream of the platelet-derived growth factor receptor. Exp. Cell Res. 279: 21-33.
26. Ho, H. Y., R. Rohatgi, L. Ma, and M. W. Kirschner. 2001. CR16 forms a complex with N-WASP in brain and is a novel member of a conserved proline-rich actin-binding protein family. Proc. Natl. Acad. Sci. USA 98: 11306-11311.
27. Vaduva, G., N. Martinez-Quiles, I. M. Anton, N. C. Martin, R. S. Geha, A. K. Hopper, and N. Ramesh. 1999. The human WASP-interacting protein, WIP, activates the cell polarity pathway in yeast. J. Biol. Chem. 274: 17103-17108.
28. Sasahara, Y., R. Rachid, M. J. Byrne, M. A. de la Fuente, R. T. Abraham, N. Ramesh, and R. S. Geha. 2002. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell 10: 1269-1281.
29. Moreau, V., F. Frischknecht, I. Reckmann, R. Vincentelli, G. Rabut, D. Stewart, and M. Way. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2: 441-448.
30. Volkman, B. F., K. E. Prehoda, J. A. Scott, F. C. Peterson, and W. A. Lim. 2002. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111: 565-576.
31. Kato, M., and T. Takenawa. 2005. WICH, a member of WASP-interacting protein family, cross-links actin filaments. Biochem. Biophys. Res. Commun. 328: 1058-1066.
32. Aspenstrom, P. 2004. The mammalian verprolin homologue WIRE participates in receptor-mediated endocytosis and regulation of the actin filament system by distinct mechanisms. Exp. Cell Res. 298: 485-498.
33. Masters, J. N., S. L. Cotman, H. H. Osterburg, N. R. Nichols, and C. E. Finch. 1996. Modulation of a novel RNA in brain neurons by glucocorticoid and mineralocorticoid receptors. Neuroendocrinology 63: 28-38.
34. Altman, L. C., R. Snyderman, and R. M. Blaese. 1974. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome. J. Clin. Invest. 54: 486-493.
35. Ochs, H. D., S. J. Slichter, L. A. Harker, W. E. Von Behrens, R. A. Clark, and R. J. Wedgwood. 1980. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 55: 243-252.
36. Van Epps, D. E., A. El-Naggar, and H. D. Ochs. 1983. Abnormalities of lymphocyte locomotion in immunodeficiency disease. Clin. Exp. Immunol. 53: 678-688.
37. Zicha, D., W. E. Allen, P. M. Brickell, C. Kinnon, G. A. Dunn, G. E. Jones, and A. J. Thrasher. 1998. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101: 659-665.
38. Majstoravich, S., J. Zhang, S. Nicholson-Dykstra, S. Linder, W. Friedrich, K. A. Siminovitch, and H. N. Higgs. 2004. Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology. Blood 104: 1396-1403.
39. Snapper, S. B., P. Meelu, D. Nguyen, B. M. Stockton, P. Bozza, F. W. Alt, F. S. Rosen, U. H. von Andrian, and C. Klein. 2005. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J. Leukocyte Biol. 77: 993-998.
40. Badolato, R., S. Sozzani, F. Malacarne, S. Bresciani, M. Fiorini, A. Borsatti, A. Albertini, A. Mantovani, A. G. Ugazio, and L. D. Notarangelo. 1998. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J. Immunol. 161: 1026-1033.
41. Jones, G. E. 2000. Cellular signaling in macrophage migration and chemotaxis. J. Leukocyte Biol. 68: 593-602.
42. Jones, G. E., D. Zicha, G. A. Dunn, M. Blundell, and A. Thrasher. 2002. Restoration of podosomes and chemotaxis in Wiskott-Aldrich syndrome macrophages following induced expression of WASp. Int. J. Biochem. Cell Biol. 34: 806-815.
43. Calle, Y., G. E. Jones, C. Jagger, K. Fuller, M. P. Blundell, J. Chow, T. Chambers, and A. J. Thrasher. 2004. WASp deficiency in mice results in failure to form osteoclast sealing zones and defects in bone resorption. Blood 103: 3552-3561.
44. Binks, M., G. E. Jones, P. M. Brickell, C. Kinnon, D. R. Katz, and A. J. Thrasher. 1998. Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome. Eur. J. Immunol. 28: 3259-3267.
45. Linder, S., H. Higgs, K. Hufner, K. Schwarz, U. Pannicke, and M. Aepfelbacher. 2000. The polarization defect of Wiskott-Aldrich syndrome macrophages is linked to dislocalization of the Arp2/3 complex. J. Immunol. 165: 221-225.
46. Allavena, P., R. Badolato, F. Facchetti, W. Vermi, C. Paganin, W. Luini, S. Giliani, C. Mazza, U. Bolzern, I. Chiesa, et al. 2001. Monocytes from Wiskott-Aldrich patients differentiate in functional mature dendritic cells with a defect in CD83 expression. Eur. J. Immunol. 31: 3413-3421.
47. Burns, S., S. J. Hardy, J. Buddle, K. L. Yong, G. E. Jones, and A. J. Thrasher. 2004. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil. Cytoskeleton 57: 118-132.
48. Ashida, N., H. Arai, M. Yamasaki, and T. Kita. 2001. Differential signaling for MCP-1-dependent integrin activation and chemotaxis. Ann. NY Acad. Sci. 947: 387-389.
49. Linder, S., D. Nelson, M. Weiss, and M. Aepfelbacher. 1999. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl. Acad. Sci. USA 96: 9648-9653.
50. Lorenzi, R., P. M. Brickell, D. R. Katz, C. Kinnon, and A. J. Thrasher. 2000. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95: 2943-2946.
51. Taylor, P. R., A. Carugati, V. A. Fadok, H. T. Cook, M. Andrews, M. C. Carroll, J. S. Savill, P. M. Henson, M. Botto, and M. J. Walport. 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192: 359-366.
52. Leverrier, Y., R. Lorenzi, M. P. Blundell, P. Brickell, C. Kinnon, A. J. Ridley, and A. J. Thrasher. 2001. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J. Immunol. 166: 4831-4834.
53. Auwerx, J. 1991. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47: 22-31.
54. Dreskin, S. C., G. W. Thomas, S. N. Dale, and L. E. Heasley. 2001. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J. Immunol. 166: 5646-5653.
55. Naqvi, S. N., R. Zahn, D. A. Mitchell, B. J. Stevenson, and A. L. Munn. 1998. The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast. Curr. Biol. 8: 959-962.
56. Stewart, D. M., L. Tian, and D. L. Nelson. 1999. Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. J. Immunol. 162: 5019-5024.
57. Linder, S., U. Wintergerst, C. Bender-Gotze, K. Schwarz, U. Pannicke, and M. Aepfelbacher. 2003. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype. Immunol. Cell Biol. 81: 130-136.
58. Anton, I. M., M. A. de la Fuente, T. N. Sims, S. Freeman, N. Ramesh, J. H. Hartwig, M. L. Dustin, and R. S. Geha. 2002. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 16: 193-204.
59. Kettner, A., L. Kumar, I. M. Anton, Y. Sasahara, M. de la Fuente, V. I. Pivniouk, H. Falet, J. H. Hartwig, and R. S. Geha. 2004. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J. Exp. Med. 199: 357-368.
60. Gallego, M. D., M. A. de la Fuente, I. M. Anton, S. Snapper, R. Fuhlbrigge, and R. S. Geha. 2006. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1α. Int. Immunol. 18: 221-232.
61. Imai, K., S. Nonoyama, and H. D. Ochs. 2003. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr. Opin. Allergy Clin. Immunol. 3: 427-436.
62. Zhu, Q., C. Watanabe, T. Liu, D. Hollenbaugh, R. M. Blaese, S. B. Kanner, A. Aruffo, and H. D. Ochs. 1997. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood 90: 2680-2689.
63. Schurman, S. H., and F. Candotti. 2003. Autoimmunity in Wiskott-Aldrich syndrome. Curr. Opin. Rheumatol. 15: 446-453.